Bellerophon Therapeutics Azioni (OTC: BLPH)

Ultime notizie per Bellerophon Therapeutics (OTC:BLPH) Azioni

Bellerophon Therapeutics

Bellerophon Therapeutics Inc is a clinical-stage therapeutics company. The firm develops innovative products combining novel drugs and devices to treat cardiopulmonary diseases. It develops products under its INOpulse platform, which is an extension of the technology that is used in hospitals to deliver continuous-flow inhaled nitric oxide. The company's products are aimed at the treatment of different kinds of pulmonary hypertension.

BELLEROPHON THERPETCS INC by Bellerophon Therapeutics, Inc.

Bellerophon Therapeutics Inc

<h3>Gainers</h3>
<ul>
<li>Bellerophon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLPH#NASDAQ">BLPH</a>) stock moved upwards by 17.1% to $0.12 during Friday's after-market session. Trading volume for this security closed at 2.1 million, accounting for 1394.7% of its average full-day volume over the last 100 days. The company's market cap stands at $1.4 million. </li>
<li>Cingulate (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CING#NASDAQ">CING</a>) stock increased by 12.59% to $0.58. The company's market cap stands at $10.0 million. </li>
<li>Rain Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAIN#NASDAQ">RAIN</a>) stock rose 11.11% to $1.1. Rain Oncology's trading volume hit 98.3K shares by close, accounting for 45.0% of its average volume over the last 100 days. The company's market cap stands at $40.0 million. </li>
<li>Artelo Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTL#NASDAQ">ARTL</a>) shares rose 9.72% to $1.58. The market value of their outstanding shares is at $4.5 million. </li>
<li>Processa Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) shares moved upwards by 8.37% to $0.52. This security traded at a volume of 751.1K shares come close, making up 347.2% of its average volume over the last 100 days. The company's market cap stands at $12.8 million. </li>
<li>Eiger BioPharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EIGR#NASDAQ">EIGR</a>) stock rose 7.78% to $0.27. The company's market cap stands at $11.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Eloxx Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELOX#NASDAQ">ELOX</a>) stock decreased by 17.5% to $3.15 during Friday's after-market session. The market value of their outstanding shares is at $9.6 million. </li>
<li>TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) stock declined by 7.66% to $0.18. At the close, TRACON Pharma's trading volume reached 9.9 million shares. This is 1727.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $5.4 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) stock declined by 7.41% to $1.0. The market value of their outstanding shares is at $3.6 million. </li>
<li>Purple Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBT#NASDAQ">PPBT</a>) shares fell 6.26% to $1.2. The market value of their outstanding shares is at $25.6 million. </li>
<li>RVL Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVLP#NASDAQ">RVLP</a>) stock declined by 6.17% to $0.07. At the close, RVL Pharmaceuticals's trading volume reached 8.8 million shares. This is 53.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $7.6 million. </li>
<li>OpGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPGN#NASDAQ">OPGN</a>) shares declined by 6.16% to $0.77. Today's trading volume for this security ended up closing at 2.1 million shares, which is 65.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $6.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ARTL

BLPH

CING

EIGR

ELOX

OPGN

PCSA

PPBT

RAIN

RVLP

TCON

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) shares rose 60.6% to $0.63 during Friday's regular session. Bio-Path Hldgs's stock is trading at a volume of 111.1 million shares as of 13:30 EST. This is 15820.7% of its average full-day volume over the last 100 days. The company's market cap stands at $7.2 million. </li>
<li>Processa Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) stock moved upwards by 22.69% to $0.41. The current volume of 5.1 million shares is 2367.4% of Processa Pharma's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $9.9 million. </li>
<li>Harpoon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HARP#NASDAQ">HARP</a>) stock increased by 20.66% to $3.97. As of 13:30 EST, Harpoon Therapeutics's stock is trading at a volume of 80.5K, which is 212.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $15.9 million. </li>
<li>SELLAS Life Sciences Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLS#NASDAQ">SLS</a>) stock rose 20.0% to $1.29. The current volume of 1.0 million shares is 417.6% of SELLAS Life Sciences Gr's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $36.5 million. </li>
<li>Agape ATP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) stock increased by 19.99% to $1.32. As of 13:30 EST, this security is trading at a volume of 2.5 million shares, making up 161.0% of its average full-day volume over the last 100 days. The company's market cap stands at $99.5 million. </li>
<li>Assure Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONM#NASDAQ">IONM</a>) shares rose 19.56% to $0.33. As of 13:30 EST, this security is trading at a volume of 1.4 million shares, making up 123.9% of its average full-day volume over the last 100 days. The company's market cap stands at $2.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bellerophon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLPH#NASDAQ">BLPH</a>) stock decreased by 64.9% to $0.14 during Friday's regular session. Trading volume for this security as of 13:30 EST is 3.3 million, which is 2157.8% of its average full-day volume over the last 100 days. The company's market cap stands at $1.6 million. </li>
<li>Outset Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OM#NASDAQ">OM</a>) shares declined by 50.23% to $3.37. Trading volume for Outset Medical's stock is 6.2 million as of 13:30 EST. This is 956.8% of its average full-day volume over the last 100 days. The company's market cap stands at $167.7 million. </li>
<li>Harmony Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRMY#NASDAQ">HRMY</a>) stock declined by 31.43% to $20.75. Harmony Biosciences's stock is trading at a volume of 5.0 million shares as of 13:30 EST. This is 885.1% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 billion. </li>
<li>Comera Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMRA#NASDAQ">CMRA</a>) stock decreased by 21.16% to $0.25. Trading volume for this security as of 13:30 EST is 357.6K, which is 365.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.7 million. </li>
<li>Catalyst Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBIO#NASDAQ">CBIO</a>) shares fell 19.76% to $0.33. Catalyst Biosciences's stock is trading at a volume of 762.9K shares as of 13:30 EST. This is 202.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.4 million. </li>
<li>PMV Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMVP#NASDAQ">PMVP</a>) shares fell 18.88% to $2.02. As of 13:30 EST, this security is trading at a volume of 3.3 million shares, making up 711.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $97.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATPC

BPTH

CBIO

CMRA

HARP

HRMY

IONM

PMVP

12 Health Care Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Sigma Additive Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sasi#NASDAQ">SASI</a>) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.</li>
<li>Bio-Path Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpth#NASDAQ">BPTH</a>) shares climbed 102% to $0.7961 after gaining more than 6% on Thursday.</li>
<li>Shift Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sft#NASDAQ">SFT</a>) gained 60% to $0.2145, after falling around 21% on Thursday.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) gained 32% to $0.5625.</li>
<li>Comtech Telecommunications Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmtl#NASDAQ">CMTL</a>) shares climbed 30.6% to $10.63 after posting better-than-expected fourth-quarter results.</li>
<li>Versus Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vs#NASDAQ">VS</a>) shares climbed 29.1% to $0.4246 after jumping more than 52% on Thursday.</li>
<li>Outlook Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otlk#NASDAQ">OTLK</a>) gained 26% to $0.3448</li>
<li>SunOpta Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stkl#NASDAQ">STKL</a>) gained 22.5% to $3.5050 after the company announced the sale of certain frozen fruit assets to Nature&#39;s Touch for an aggregate purchase price of $141 million and issued preliminary Q3 results.</li>
<li>PSQ Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/psqh#NYSE">PSQH</a>) climbed 22% to $5.55. The company said preliminary third quarter revenue climbed around 300% sequentially, to an estimated $2.2 million, representing 1,600% year-over-year growth.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) jumped 21% to $20.77 after the company obtained a type certificate for the EH216-S passenger-carrying UAV system issued by the Civil Aviation Administration of China.</li>
<li>SELLAS Life Sciences Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sls#NASDAQ">SLS</a>) gained 18% to $1.27. SELLAS Life Sciences issued an update on Phase 3 REGAL clinical trial for Galinpepimut-S in acute myeloid leukemia.</li>
<li>Celularity Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celu#NASDAQ">CELU</a>) rose 17.7% to $0.3179.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcsa#NASDAQ">PCSA</a>) gained 16% to $0.3826.</li>
<li>Hecla Mining Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hl#NYSE">HL</a>) climbed 13.7% to $4.1650 after Roth MKM upgraded the stock from Neutral to Buy and raised its price target from $4 to $4.4.</li>
<li>Viasat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vsat#NASDAQ">VSAT</a>) climbed 13.5% to $19.06.</li>
<li>Coeur Mining, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cde#NYSE">CDE</a>) gained 13.2% to $2.5399.</li>
<li>Groupon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grpn#NASDAQ">GRPN</a>) jumped 13.2% to $12.38 after Roth MKM initiated coverage on the stock with a Buy rating and $30 price target.</li>
<li>Synchronoss Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sncr#NASDAQ">SNCR</a>) surged 13% to $0.5426.</li>
<li>Oblong, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oblg#NASDAQ">OBLG</a>) shares gained 12.1% to $0.3286.</li>
<li>Blue Star Foods Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsfc#NASDAQ">BSFC</a>) shares gained 10% to $0.2201.</li>
<li>Staffing 360 Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/staf#NASDAQ">STAF</a>) rose 9.2% to $0.7550.</li>
<li>Dollar General Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dg#NYSE">DG</a>) climbed 8.5% to $110.50 after the company updated financial guidance for FY23 and announced Todd Vasos has been appointed CEO.</li>
<li>First Majestic Silver Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ag#NYSE">AG</a>) climbed 8.5% to $5.34.</li>
<li>The Progressive Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pgr#NYSE">PGR</a>) gained 7.7% to $154.27 after the company reported third-quarter results.</li>
<li>RedHill Biopharma Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdhl#NASDAQ">RDHL</a>) rose 6.9% to $0.3976. RedHill Biopharma recently said that its oral opaganib shows a significant increase in survival time (at 150 mg/kg twice daily dose) in a U.S. Army-funded in vivo Ebola virus study, making it the first host-directed molecule to show activity in the Ebola virus disease.</li>
<li>JPMorgan Chase &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jpm#NYSE">JPM</a>) gained 3.6% to $151.09 as the company reported better-than-expected earnings for its third quarter on Friday.</li>
<li>Wells Fargo &amp; Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wfc#NYSE">WFC</a>) gained 3.2% to $41.03 following third-quarter earnings.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bellerophon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blph#NASDAQ">BLPH</a>) fell 53.4% to $0.1852.</li>
<li>Outset Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/om#NASDAQ">OM</a>) shares fell 47.6% to $3.55. The company announced preliminary revenue for the third quarter of $30.4 million, below the consensus estimate of $36.03 million.</li>
<li>MSP Recovery, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lifw#NASDAQ">LIFW</a>) dipped 44% to $1.8109.</li>
<li>SMART Global Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgh#NASDAQ">SGH</a>) fell 40.4% to $14.04 after the company reported worse-than-expected fourth-quarter financial results and issued a weak forecast for the first quarter.</li>
<li>Harmony Biosciences Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrmy#NASDAQ">HRMY</a>) declined 38.3% to $18.66 after the company reported topline data from its Phase 3 INTUNE study of pitolisant for IH, noting no statistically significant difference was observed</li>
<li>between pitolisant and placebo on ESS.</li>
<li>Secoo Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seco#NASDAQ">SECO</a>) fell 38% to $0.6327.</li>
<li>FLJ Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flj#NASDAQ">FLJ</a>) fell 31.9% to $0.2301.</li>
<li>PMV Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmvp#NASDAQ">PMVP</a>) declined 27.7% to $1.7999. PMV Pharmaceuticals recently announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed PC14586 achieved efficacy in heavily pretreated patients across multiple tumor types and was well tolerated with a favorable safety profile.</li>
<li>LQR House Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lqr#NASDAQ">LQR</a>) declined 26.6% to $0.1739 after the company announced the pricing of a $5.4 million public offering of 28,421,053 shares of common stock at a price of $0.19 per share.</li>
<li>Belden Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bdc#NYSE">BDC</a>) fell 25.7% to $70.76 after the company lowered third-quarter revenue guidance below estimates.</li>
<li>Scully Royalty Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/srl#NYSE">SRL</a>) declined 25% to $4.1990.</li>
<li>Charles &amp; Colvard, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cthr#NASDAQ">CTHR</a>) fell 23% to $0.44 following quarterly results.</li>
<li>Cassava Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sava#NASDAQ">SAVA</a>) fell 21.3% to $13.80 after a recent report by the City University of New York implicated a long-time collaborator of the company in scientific misconduct related to 20 research papers.</li>
<li>Edesa Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edsa#NASDAQ">EDSA</a>) shares fell 21.1% to $3.8501 after jumping around 80% on Thursday. Edesa Biotech secured a commitment of up to C$23 million from the Government of Canada for a pivotal Phase 3 clinical study of the company&#39;s first-in-class therapeutic candidate.</li>
<li>Prestige Wealth Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pwm#NASDAQ">PWM</a>) fell 18.7% to $3.43.</li>
<li>ReShape Lifesciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rsls#NASDAQ">RSLS</a>) fell 17.9% to $0.2795, after surging over 25% on Thursday.</li>
<li>Nuwellis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nuwe#NASDAQ">NUWE</a>) fell 17.8% to $0.8301. Nuwellis reported pricing of $2.25 million public offering of Series J convertible redeemable preferred stock and warrants.</li>
<li>Tian Ruixiang Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tirx#NASDAQ">TIRX</a>) fell 15.7% to $0.8850, after jumping 28% on Thursday.</li>
<li>BeyondSpring Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bysi#NASDAQ">BYSI</a>) shares fell 15.1% to $0.9089, after jumping 46% on Thursday.</li>
<li>ATRenew Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rere#NYSE">RERE</a>) declined 13.4% to $1.8350.</li>
<li>Tango Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tngx#NASDAQ">TNGX</a>) fell 11.5% to $6.90.</li>
<li>Sterling Infrastructure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/strl#NASDAQ">STRL</a>) fell 11.2% to $68.79.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) fell 9.9% to $9.91.</li>
<li>LogicMark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgmk#NASDAQ">LGMK</a>) shares fell 9.7% to $1.76 after jumping around 25% on Thursday.</li>
<li>Society Pass Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sopa#NASDAQ">SOPA</a>) shares fell 9.7% to $0.3201. Society Pass shares jumped around 33% on Thursday after the company announced an equity line of up to $40 million to invest into operating subsidiaries projected to go public in 2024.</li>
<li>Ribbon Communications Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rbbn#NASDAQ">RBBN</a>) declined 8.8% to $2.2050.</li>
<li>Hormel Foods Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrl#NYSE">HRL</a>) fell 4.5% to $30.93 following the company&#39;s Thursday investor day event. Additionally, Goldman Sachs maintained a Sell rating on the stock and lowered its price target from $33 to $29.</li>
<li>JD.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jd#NASDAQ">JD</a>) fell 4.1% to $26.71. Macquarie downgraded JD.com from Outperform to Neutral and lowered the price target from $52 to $32, while Morgan Stanley downgraded the stock from Overweight to Equal-Weight and slashed the price target from $55 to $33.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35234932/cramer-likes-this-industrial-stock-a-well-run-company-doing-a-lot-of-good-things"> Cramer Likes This Industrial Stock: A &#39;Well-Run&#39; Company Doing &#39;A Lot Of Good Things&#39;</a>

News

Penny Stocks

Small Cap

Intraday Update

Markets

Trading Ideas

BSFC

BYSI

CELU

CISS

CMTL

CTHR

EDSA

GRPN

LGMK

LIFW

NUWE

OBLG

OTLK

PSQH

RBBN

RDHL

RERE

RSLS

SASI

SAVA

SECO

SNCR

SOPA

STAF

STKL

STRL

TIRX

TNGX

VSAT

Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session

U.S. stocks traded mostly higher this morning, with the Dow Jones gaining more than 200 points on Friday.
Following the market opening Friday, the Dow traded up 0.74% to 33,880.85 while the NASDAQ rose 0.04% to 13,579.61. The S&amp;P 500 also rose, gaining, 0.41% to 4,367.33.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35239191/top-5-tech-and-telecom-stocks-that-may-explode-this-month"> Top 5 Tech And Telecom Stocks That May Explode This Month</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Energy shares climbed by 1.7% on Friday.
In trading on Friday, information technology shares rose by just 0.1%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
JPMorgan Chase &amp; Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jpm#NYSE">JPM</a>) reported better-than-expected earnings for its third quarter on Friday.
JPMorgan reported quarterly net revenue (managed) of $40.7 billion, up 21% Y/Y, beating the consensus of $39.57 billion. EPS was $4.33, beating the consensus of $3.96.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Sigma Additive Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sasi#NASDAQ">SASI</a>) shares shot up 172% to $6.85 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.
Shares of Bio-Path Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpth#NASDAQ">BPTH</a>) got a boost, shooting 111% to $0.83 after gaining more than 6% on Thursday.
Versus Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vs#NASDAQ">VS</a>) shares were also up, gaining 55% to $0.5131 after jumping more than 52% on Thursday.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Outset Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/om#NASDAQ">OM</a>) shares dropped 50% to $3.40. The company announced preliminary revenue for the third quarter of $30.4 million, below the consensus estimate of $36.03 million.
Shares of Bellerophon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blph#NASDAQ">BLPH</a>) were down 45% to $0.2201.
Secoo Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seco#NASDAQ">SECO</a>) was down, falling 35% to $0.6626.
Also Check This Out:<a href="https://www.benzinga.com/news/earnings/23/10/35234786/how-to-earn-500-a-month-from-walgreens-boots-alliance-stock-after-weak-earnings"> How To Earn $500 A Month From Walgreens Boots Alliance Stock After Weak Earnings</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 3.8% to $86.05 while gold traded up 2% at $1,920.90.
Silver traded up 2.7% to $22.56 on Friday while copper fell 0.4% to $3.5765.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were lower today. The eurozone&rsquo;s STOXX 600 fell 0.4% London&rsquo;s FTSE 100 fell 0.1% while Spain&rsquo;s IBEX 35 Index fell 0.6% The German DAX fell 0.8% French CAC 40 fell 0.7%, while Italy&rsquo;s FTSE MIB Index fell 0.4%.
Spain&#39;s annual consumer price inflation rose to a five-month high of 3.5% in September from 2.6% in August. The annual inflation rate in France came in at 4.9% in September, unchanged versus the prior month.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Friday, with Japan&rsquo;s Nikkei 225 falling 0.55%, China&rsquo;s Shanghai Composite Index falling 2.33% and Hong Kong&rsquo;s Hang Seng Index dropping 0.64%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, slipped 0.2%.
India recorded a merchandise trade deficit of $19.4 billion in September, compared to market expectations of a $23.3 billion gap. China&#39;s producer prices declined 2.5% year-over-year in September, while consumer prices came in unchanged from a year-ago in September.
&nbsp;
<h3>Economics</h3>
&nbsp;
Export prices in the U.S. increased by 0.7% month-over-month in September.
Import prices rose 0.1% month-over-month in September.
Now Read This: <a href="https://www.benzinga.com/news/23/10/35239431/caleres-cloudflare-and-2-other-stocks-insiders-are-selling"> Caleres, Cloudflare And 2 Other Stocks Insiders Are Selling </a>

Earnings

Eurozone

Commodities

Global

Dow Jumps Over 200 Points; JPMorgan Earnings Top Estimates

<h3>Gainers</h3>
<ul>
<li>Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) stock rose 132.2% to $0.92 during Friday's pre-market session. The company's market cap stands at $10.4 million. </li>
<li>Redhill Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDHL#NASDAQ">RDHL</a>) stock moved upwards by 34.4% to $0.5. The company's market cap stands at $2.9 million. </li>
<li>Akari Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTX#NASDAQ">AKTX</a>) shares rose 14.52% to $4.02. The market value of their outstanding shares is at $20.3 million. </li>
<li>TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) stock moved upwards by 14.42% to $0.22. The market value of their outstanding shares is at $6.7 million. </li>
<li>Petros Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) shares increased by 13.94% to $1.74. The company's market cap stands at $3.6 million. </li>
<li>Sera Prognostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>) shares increased by 12.76% to $2.12. The company's market cap stands at $66.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Outset Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OM#NASDAQ">OM</a>) shares declined by 39.3% to $4.11 during Friday's pre-market session. The market value of their outstanding shares is at $204.6 million. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) shares decreased by 35.15% to $0.66. The market value of their outstanding shares is at $1.2 million. </li>
<li>Bellerophon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLPH#NASDAQ">BLPH</a>) shares decreased by 31.86% to $0.26. The company's market cap stands at $3.2 million. </li>
<li>Cassava Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) shares decreased by 29.88% to $12.3. The market value of their outstanding shares is at $516.2 million. </li>
<li>OpGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPGN#NASDAQ">OPGN</a>) shares fell 25.1% to $0.69. The market value of their outstanding shares is at $6.1 million. </li>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) shares decreased by 16.18% to $0.28. The market value of their outstanding shares is at $1.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKTX

PTPI

SERA

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) stock increased by 158.8% to $1.02 during Thursday's after-market session. Today's trading volume for this security ended up closing at 18.9 million shares, which is 5623.9 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $11.6 million. </li>
<li>Comera Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMRA#NASDAQ">CMRA</a>) shares increased by 63.0% to $0.52. At the close, Comera Life Sciences's trading volume reached 572.6K shares. This is 1127.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $15.9 million. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) stock rose 17.02% to $0.77. The company's market cap stands at $3.6 million. </li>
<li>60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) stock moved upwards by 16.69% to $0.82. The company's market cap stands at $4.7 million. </li>
<li>Bellerophon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLPH#NASDAQ">BLPH</a>) shares increased by 13.35% to $0.45. The company's market cap stands at $5.5 million. </li>
<li>Relay Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLAY#NASDAQ">RLAY</a>) stock moved upwards by 12.01% to $8.86. Today's trading volume for this security ended up closing at 175.8K shares, which is 18.0 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cassava Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) stock decreased by 44.2% to $9.79 during Thursday's after-market session. This security traded at a volume of 761.8K shares come close, making up 92.6% of its average volume over the last 100 days. The company's market cap stands at $410.8 million. </li>
<li>Outset Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OM#NASDAQ">OM</a>) stock decreased by 33.24% to $4.52. This security traded at a volume of 421.5K shares come close, making up 66.4% of its average volume over the last 100 days. The company's market cap stands at $225.0 million. </li>
<li>T2 Biosystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTOO#NASDAQ">TTOO</a>) stock decreased by 29.66% to $0.12. Today's trading volume for this security ended up closing at 84.9 million shares, which is 77.0 percent of its average volume over the last 100 days. The company's market cap stands at $40.8 million. </li>
<li>OpGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPGN#NASDAQ">OPGN</a>) stock decreased by 21.74% to $0.72. Today's trading volume for this security ended up closing at 21.0 million shares, which is 937.9 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $6.4 million. </li>
<li>Tempest Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) shares decreased by 14.33% to $3.41. At the close, Tempest Therapeutics's trading volume reached 8.0 million shares. This is 251.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $45.4 million. </li>
<li>BeyondSpring (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYSI#NASDAQ">BYSI</a>) shares declined by 13.98% to $0.92. The market value of their outstanding shares is at $35.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RLAY

SCNI

SXTP

Tempest Therapeutics, Inc. - Common Stock

TPST

TTOO

12 Health Care Stocks Moving In Thursday's After-Market Session

<h1>&nbsp;</h1>
Friday&#39;s session saw 59 companies set new 52-week lows.
<h2>Interesting Facts About Today&#39;s 52-Week Lows:</h2>
<ul>
<li>Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) was the largest firm by market cap to set a new 52-week low.</li>
<li>BitNile Metaverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNMV#NASDAQ">BNMV</a>) was the smallest company in terms of market cap to set a new 52-week low.</li>
<li>Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) saw the largest move of the companies, as shares plummetted 38.2% to hit a new 52-week low.</li>
<li>ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>)&#39;s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.</li>
</ul>
The following stocks created new 52-week lows on Friday:
<ul>
<li>Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) shares were up 0.07% for the day, having made a 52-week low of $60.05.</li>
<li>TC Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRP#NYSE">TRP</a>) shares were down 4.72% for the day, having made a 52-week low of $33.05.</li>
<li>Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) shares were down 10.61% for the day, having made a 52-week low of $145.67.</li>
<li>Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) shares made a new 52-week low of $27.90 on Friday. The stock was down 5.79% for the day.</li>
<li>NovoCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) shares set a new 52-week low of $32.51. The stock traded down 2.86%.</li>
<li>Clearway Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWEN#NYSE">CWEN</a>) stock hit a yearly low of $26.30. The stock was down 0.26% for the day.</li>
<li>TELUS Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIXT#NYSE">TIXT</a>) shares set a new 52-week low of $9.31. The stock traded down 0.21%.</li>
<li>Impinj (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) stock hit a new 52-week low of $65.47. The stock was down 5.13% on the session.</li>
<li>Maravai LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) stock broke to a new 52-week low of $11.12 on Friday. Shares of the company traded up 0.39%.</li>
<li>Baijiayun Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>) shares fell to $6.29 on Friday, setting a new 52-week low with a shift of up 3.69%.</li>
<li>2seventy bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSVT#NASDAQ">TSVT</a>) stock achieved a new 52-week low on Friday morning, hitting $7.46 and moving down 7.08%.</li>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) shares set a new 52-week low of $6.72. The stock traded up 0.87%.</li>
<li>TPI Composites (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) shares reached a new 52-week low of $5.56 on Friday morning, moving down 6.52%.</li>
<li>Prelude Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRLD#NASDAQ">PRLD</a>) stock hit $3.96 on Friday morning, setting a new 52-week low for a change of down 3.12%.</li>
<li>Rimini Street (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMNI#NASDAQ">RMNI</a>) stock set a new 52-week low of $2.26 on Friday, moving down 2.33%.</li>
<li>Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) shares moved up 2.56% on Friday to hit a new 52-week low of $0.87, drifting up 2.56%.</li>
<li>NGM Biopharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGM#NASDAQ">NGM</a>) stock drifted down 0.44% on Friday morning to hit a new 52-week low of $2.23.</li>
<li>Nouveau Monde Graphite (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMG#NYSE">NMG</a>) stock set a new 52-week low of $2.73 on Friday, moving down 4.83%.</li>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) shares set a new yearly low of $3.50 this morning. The stock was down 1.87% on the session.</li>
<li>ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) shares set a new 52-week low of $6.25. The stock traded 0.0% (flat).</li>
<li>Electrovaya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) stock set a new 52-week low of $4.11 on Friday, moving down 3.17%.</li>
<li>NioCorp Developments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NB#NASDAQ">NB</a>) stock hit $4.35 on Friday morning, setting a new 52-week low for a change of up 1.37%.</li>
<li>Aadi Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AADI#NASDAQ">AADI</a>) stock hit a yearly low of $5.17. The stock was down 3.35% for the day.</li>
<li>G1 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTHX#NASDAQ">GTHX</a>) stock set a new 52-week low of $2.31 on Friday, moving up 1.29%.</li>
<li>Eargo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAR#NASDAQ">EAR</a>) shares hit a yearly low of $3.88. The stock was up 2.31% on the session.</li>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFW#NASDAQ">LIFW</a>) stock hit a new 52-week low of $0.20. The stock was up 10.04% on the session.</li>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) shares hit a yearly low of $1.53. The stock was down 9.94% on the session.</li>
<li>Delta Apparel (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DLA#AMEX">DLA</a>) shares reached a new 52-week low of $8.71 on Friday morning, moving down 0.4%.</li>
<li>Airgain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>) stock hit a new 52-week low of $4.61. The stock was down 2.71% on the session.</li>
<li>Leap Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTX#NASDAQ">LPTX</a>) stock set a new 52-week low of $2.26 on Friday, moving up 5.79%.</li>
<li>Phoenix New Media (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FENG#NYSE">FENG</a>) stock hit a yearly low of $1.63. The stock was down 6.78% for the day.</li>
<li>Strong Global (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGE#AMEX">SGE</a>) shares hit a yearly low of $2.40. The stock was up 2.0% on the session.</li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) shares made a new 52-week low of $3.42 on Friday. The stock was down 0.83% for the day.</li>
<li>Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) shares made a new 52-week low of $1.01 on Friday. The stock was down 38.2% for the day.</li>
<li>Golden Minerals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#AMEX">AUMN</a>) shares moved down 3.88% on Friday to hit a new 52-week low of $1.20, drifting down 3.88%.</li>
<li>China Jo-Jo Drugstores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJJD#NASDAQ">CJJD</a>) shares set a new yearly low of $0.36 this morning. The stock was down 0.5% on the session.</li>
<li>Precipio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) stock hit a new 52-week low of $0.31. The stock was down 0.25% on the session.</li>
<li>ABVC BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVC#NASDAQ">ABVC</a>) stock hit a yearly low of $2.61. The stock was down 14.19% for the day.</li>
<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) stock drifted down 5.04% on Friday morning to hit a new 52-week low of $0.26.</li>
<li>Siyata Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) shares set a new 52-week low of $0.04. The stock traded down 7.05%.</li>
<li>Applied UV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUVI#NASDAQ">AUVI</a>) stock drifted down 2.37% on Friday morning to hit a new 52-week low of $0.80.</li>
<li>TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) shares fell to $0.26 on Friday, setting a new 52-week low with a shift of down 3.18%.</li>
<li>Micromobility com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCOM#NASDAQ">MCOM</a>) stock hit a new 52-week low of $0.07. The stock was down 7.85% on the session.</li>
<li>FOXO Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#AMEX">FOXO</a>) stock drifted up 0.89% on Friday morning to hit a new 52-week low of $0.13.</li>
<li>Lixte Biotech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) stock dropped to a yearly low on Friday of $3.23. Shares traded down 7.61%.</li>
<li>Bellerophon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLPH#NASDAQ">BLPH</a>) stock set a new 52-week low of $0.39 on Friday, moving down 3.71%.</li>
<li>Adamis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMP#NASDAQ">ADMP</a>) shares were down 7.41% for the day, having made a 52-week low of $1.45.</li>
<li>Ault Alliance (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AULT#AMEX">AULT</a>) stock set a new 52-week low of $2.78 on Friday, moving down 1.68%.</li>
<li>C3is (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISS#NASDAQ">CISS</a>) stock hit $0.55 on Friday morning, setting a new 52-week low for a change of up 2.42%.</li>
<li>EBET (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBET#NASDAQ">EBET</a>) shares set a new 52-week low of $0.08. The stock traded down 0.29%.</li>
<li>Gaucho Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINO#NASDAQ">VINO</a>) shares set a new 52-week low of $0.48. The stock traded down 3.92%.</li>
<li>Kiromic BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRBP#NASDAQ">KRBP</a>) stock hit a yearly low of $2.46. The stock was down 3.68% for the day.</li>
<li>Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) shares set a new 52-week low of $0.18. The stock traded down 9.71%.</li>
<li>G Medical Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMVD#NASDAQ">GMVD</a>) shares were down 14.96% for the day, having made a 52-week low of $0.27.</li>
<li>Ucommune International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UK#NASDAQ">UK</a>) shares set a new 52-week low of $0.33. The stock traded down 4.81%.</li>
<li>Esports Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMBL#NASDAQ">GMBL</a>) shares made a new 52-week low of $0.41 on Friday. The stock was down 1.49% for the day.</li>
</ul>
Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. <a href="https://pro.benzinga.com/?afmc=2a&amp;utm_source=benzinga.com&amp;utm_medium=web&amp;utm_campaign=premium_products">Learn more here</a>.

Options

AADI

ABVC

ADAP

ADMP

AIRG

APLS

ATXG

AULT

AUMN

AUVI

AVTX

BNMV

CJJD

CLPT

CSLR

CWEN

EBET

ELVA

ENPH

FENG

FOXO

GMBL

GMVD

GTHX

KRBP

LIXT

LPTX

MCOM

MRVI

NVCR

PBTS

PRLD

PRPO

RMNI

SYTA

TIXT

TNXP

TPIC

TSVT

VINO

Stocks That Hit 52-Week Lows On Friday

<h3>Gainers</h3>
<ul>
<li>Reata Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RETA#NASDAQ">RETA</a>) shares rose 52.2% to $165.24 during Friday's pre-market session. The market value of their outstanding shares is at $6.2 billion. </li>
<li>Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) shares rose 35.7% to $7.26. The company's market cap stands at $7.4 million. </li>
<li>SIGA Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGA#NASDAQ">SIGA</a>) stock increased by 26.74% to $6.45. The company's market cap stands at $459.7 million. </li>
<li>Homology Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIXX#NASDAQ">FIXX</a>) shares moved upwards by 22.34% to $1.15. The market value of their outstanding shares is at $66.4 million. </li>
<li>Creative Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELZ#NASDAQ">CELZ</a>) shares rose 17.43% to $6.6. The market value of their outstanding shares is at $9.2 million. </li>
<li>Asensus Surgical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASXC#AMEX">ASXC</a>) stock increased by 11.63% to $0.33. The market value of their outstanding shares is at $80.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) shares decreased by 42.7% to $1.02 during Friday's pre-market session. The company's market cap stands at $10.5 million. </li>
<li>Bellerophon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLPH#NASDAQ">BLPH</a>) shares declined by 15.8% to $0.38. The company's market cap stands at $4.0 million. </li>
<li>Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) stock decreased by 15.47% to $0.71. The market value of their outstanding shares is at $10.7 million. </li>
<li>Telesis Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares fell 12.35% to $1.42. The market value of their outstanding shares is at $42.2 million. </li>
<li>Mallinckrodt (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MNK#AMEX">MNK</a>) stock fell 10.55% to $1.45. The company's market cap stands at $19.0 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares decreased by 10.0% to $0.53. The market value of their outstanding shares is at $7.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASXC

BJDX

CELZ

FEMY

FIXX

RETA

SIGA

TBIO

TTNP

<h3>Gainers</h3>
<ul>
<li>Unique Fabricating, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ufab#NASDAQ">UFAB</a>) shares surged 62.6% to $0.3512 in pre-market trading after gaining 12% on Thursday.</li>
<li>Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) rose 34.3% to $0.6647 in pre-market trading after jumping 90% on Thursday.</li>
<li>SIGA Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/siga#NASDAQ">SIGA</a>) gained 29.3% to $6.58 in pre-market trading after the company announced a $138 million US government contract for oral and IV TPOXX treatment.</li>
<li>Homology Medicines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fixx#NASDAQ">FIXX</a>) shares gained 24.5% to $1.17 in pre-market trading after the company announced plans to evaluate strategic options. The company is also reducing its workforce by 87%.</li>
<li>Inpixon (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inpx#NASDAQ">INPX</a>) shares rose 20% to $0.2424 in pre-market trading after falling around 20% on Thursday. Inpixon recently agreed to merge with XTI Aircraft Company.</li>
<li>AEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lidr#NASDAQ">LIDR</a>) shares climbed 17.8% to $0.2620 in pre-market trading after falling around 4% on Thursday.</li>
<li>Coursera, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cour#NYSE">COUR</a>) shares gained 15.3% to $15.00 in pre-market trading following better-than-expected second-quarter sales results. Cantor Fitzgerald upgraded Coursera from Neutral to Overweight and raised the price target from $13 to $17.</li>
<li>Navidea Biopharmaceuticals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/navb#NYSE">NAVB</a>) rose 10.7% to $0.1030 in pre-market trading. Navidea Biopharmaceuticals named Craig A. Dais as CFO.</li>
<li>Intel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>) shares rose 7.1% to $37.01 in pre-market trading after the company reported better-than-expected second-quarter results and issued strong guidance.</li>
<li>Asensus Surgical, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asxc#NYSE">ASXC</a>) gained 7% to $0.3210 in pre-market trading. Asensus Surgical shares fell over 40% on Thursday after the company announced $10 million registered direct offering.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Tonix Pharmaceuticals Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnxp#NASDAQ">TNXP</a>) fell 39.3% to $1.08 in pre-market trading. Tonix Pharmaceuticals priced public offering of 7 million common shares at $1 per share.</li>
<li>Sleep Number Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snbr#NASDAQ">SNBR</a>) fell 28.8% to $27.39 in pre-market trading after the company reported mixed second-quarter results.</li>
<li>Bellerophon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blph#NASDAQ">BLPH</a>) fell 18.8% to $0.3702 in pre-market trading. Bellerophon Therapeutics recently received a delisting notice.</li>
<li>Mallinckrodt plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mnk#NYSE">MNK</a>) fell 17.3% to $1.34 in pre-market trading after jumping over 28% on Thursday.</li>
<li>Fresh Vine Wine, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vine#NYSE">VINE</a>) shares fell 15.1% to $0.5350 in pre-market trading. Fresh Vine Wine said on</li>
<li>July 14, Roger Cockroft&#39;s employment with and service as CEO of the company ended and Hitesh Dheri&#39;s employment with and service as CFO ended.</li>
<li>Enphase Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enph#NASDAQ">ENPH</a>) shares fell 13.7% to $143.82 in pre-market trading after the company posted downbeat second-quarter sales and issued weak sales guidance.</li>
<li>Femasys Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/femy#NASDAQ">FEMY</a>) shares fell 13.5% to $0.7265 in pre-market trading. Femasys shares jumped over 130% on Thursday after the company announced that the United States Patent and Trademark Office issued a Notice of Allowance for FemBloc for permanent birth control.</li>
<li>Sigma Additive Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sasi#NASDAQ">SASI</a>) fell 12.1% to $0.2022 in pre-market.</li>
<li>Sweetgreen, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sg#NYSE">SG</a>) fell 11% to $13.75 in pre-market trading after the company reported worse-than-expected second-quarter results.</li>
<li>Yoshiharu Global Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yosh#NASDAQ">YOSH</a>) fell 10.6% to $0.59 in pre-market trading after dipping over 8% on Thursday.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/07/33437167/intel-procter-gamble-and-3-stocks-to-watch-heading-into-friday"> Intel, Procter &amp; Gamble And 3 Stocks To Watch Heading Into Friday</a>

Pre-Market Outlook

COUR

GBNH

INPX

INTC

LIDR

NAVB

SNBR

UFAB

VINE

YOSH

Why Coursera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Lixte Biotech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) stock increased by 13.5% to $4.45 during Wednesday's after-market session. The market value of their outstanding shares is at $8.2 million. </li>
<li>Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) shares moved upwards by 12.84% to $383.5. Align Tech's trading volume hit 77.4K shares by close, accounting for 10.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $29.3 billion. The company's, Q2 earnings came out today. </li>
<li>Mallinckrodt (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MNK#AMEX">MNK</a>) shares moved upwards by 9.52% to $1.38. This security traded at a volume of 4.2 million shares come close, making up 254.1% of its average volume over the last 100 days. The company's market cap stands at $18.1 million. </li>
<li>AIM ImmunoTech (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AIM#AMEX">AIM</a>) shares moved upwards by 6.43% to $0.61. The company's market cap stands at $29.5 million. </li>
<li>Celularity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELU#NASDAQ">CELU</a>) shares increased by 5.68% to $0.37. Trading volume for this security closed at 163.6K, accounting for 25.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $66.7 million. </li>
<li>Intensity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>) stock moved upwards by 5.24% to $6.22. The market value of their outstanding shares is at $85.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aceragen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGN#NASDAQ">ACGN</a>) shares declined by 9.3% to $0.81 during Wednesday's after-market session. The market value of their outstanding shares is at $6.8 million. </li>
<li>Infinity Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFI#NASDAQ">INFI</a>) stock declined by 7.86% to $0.13. The company's market cap stands at $11.5 million. </li>
<li>Edwards Lifesciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) shares declined by 6.17% to $85.98. Trading volume for this security closed at 229.9K, accounting for 8.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $52.1 billion. The company's, Q2 earnings came out today. </li>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) stock declined by 5.64% to $2.51. The company's market cap stands at $6.2 million. </li>
<li>icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) shares declined by 5.61% to $3.2. The market value of their outstanding shares is at $81.4 million. </li>
<li>Bellerophon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLPH#NASDAQ">BLPH</a>) stock fell 5.4% to $0.44. This security traded at a volume of 81.3K shares come close, making up 13.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $4.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACGN

ALGN

ICAD

INFI

INTS

PSTV

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>PacWest Bancorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pacw#NASDAQ">PACW</a>) shares surged 35.6% to $10.43 in pre-market trading after the company announced a merger with Banc of California. PacWest Bancorp also reported upbeat quarterly earnings.</li>
<li>Warrantee Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrnt#NASDAQ">WRNT</a>) rose 30.9% to $5.63 in pre-market trading. Warrantee priced its IPO of 2,400,000 American Depositary Shares at $4 per ADS on Tuesday.</li>
<li>AERWINS Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/awin#NASDAQ">AWIN</a>) shares gained 22.1% to $0.2949 in pre-market trading after declining around 7% on Tuesday.</li>
<li>Banc of California, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/banc#NYSE">BANC</a>) gained 15.1% to $16.82 in pre-market trading after the company announced a merger with PacWest. Banc of California also posted better-than-expected quarterly earnings.</li>
<li>DISH Network Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dish#NASDAQ">DISH</a>) gained 13.3% to $8.75 in pre-market trading amid reports of the company looking to sell its premium wireless service on Amazon.com later this week.</li>
<li>Golden Heaven Group Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdhg#NASDAQ">GDHG</a>) shares gained 13.1% to $4.16 in pre-market trading. Golden Heaven Group is expected to hold the extraordinary general meeting of shareholders on Aug. 11, 2023.</li>
<li>AIM ImmunoTech Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aim#NYSE">AIM</a>) shares climbed 12.3% to $0.73 in pre-market trading after falling 5% on Tuesday.</li>
<li>Tenable Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tenb#NASDAQ">TENB</a>) rose 11.9% to $49.00 in pre-market trading after the company reported better-than-expected third-quarter earnings and issued strong guidance.</li>
<li>AgileThought, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agil#NASDAQ">AGIL</a>) shares rose 8.1% to $1.07 in pre-market trading. Cantor Fitzgerald recently reiterated AgileThought with a Neutral and maintained a $2 price target.</li>
<li>Alphabet Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) shares rose 6.9% to $130.66 in pre-market trading after the company reported better-than-expected second-quarter results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Dunxin Financial Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dxf#NYSE">DXF</a>) fell 41.6% to $1.08 in pre-market trading after the company reported pricing of $1.09 million registered direct offering.</li>
<li>Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) fell 18.6% to $10.18 in pre-market trading after the company reported third-quarter results.</li>
<li>Aurora Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aurc#NASDAQ">AURC</a>) fell 15.3% to $28.40 in pre-market trading after jumping over 220% on Tuesday.</li>
<li>AppHarvest, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apph#NASDAQ">APPH</a>) fell 14.1% to $0.0814 in pre-market trading after gaining 5% on Tuesday. AppHarvest recently announced Chapter 11 filing to support a financial and operational transition.</li>
<li>Yoshiharu Global Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yosh#NASDAQ">YOSH</a>) shares fell 13.4% to $0.7820 in pre-market trading after jumping 41% on Tuesday.</li>
<li>BioSig Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsgm#NASDAQ">BSGM</a>) shares fell 9.5% to $0.8438 in pre-market trading after declining 12% on Tuesday. BioSig AI Sciences received $2.2 million in seed funding to advance development of artificial intelligence applications.</li>
<li>Onfolio Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onfo#NASDAQ">ONFO</a>) fell 9.5% to $0.950 in pre-market trading after gaining 10% on Tuesday.</li>
<li>Bellerophon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blph#NASDAQ">BLPH</a>) fell 9.3% to $0.4344 in pre-market. Bellerophon Therapeutics shares declined over 32% on Tuesday after the company received a delisting notice.</li>
<li>Tupperware Brands Corporation&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tup#NYSE">TUP</a>) fell 9% to $1.21 in pre-market trading after declining around 16% on Tuesday.</li>
<li>Microsoft Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>) shares fell 3.7% to $338.13 in pre-market trading. Microsoft reported better-than-expected earnings and sales results for its fourth quarter, but issued weak sales outlook for the current quarter.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/07/33385756/coca-cola-microsoft-and-3-stocks-to-watch-heading-into-wednesday"> Coca-Cola, Microsoft And 3 Stocks To Watch Heading Into Wednesday </a>

AGIL

APPH

AURC

AWIN

BANC

BSGM

DISH

GDHG

GOOGL

MSFT

ONFO

PACW

SNAP

TENB

WRNT

Why PacWest Bancorp Shares Are Trading Higher By Over 35%; Here Are 20 Stocks Moving Premarket

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday.
The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05. The S&amp;P 500, also rose, gaining, 0.48% to 4,576.60.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/07/33320168/galectin-therapeutics-and-3-other-stocks-under-2-insiders-are-buying"> Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
<ul>
<li>Materials shares climbed by 1.8% on Tuesday.</li>
<li>In trading on Tuesday, real estate shares fell by 0.6%.</li>
</ul>
&nbsp;
<h3>Top Headline</h3>
Verizon Communications Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vz#NYSE">VZ</a>) reported better-than-expected earnings for its second quarter.
It clocked a sales decline of 3.5% year-on-year to $32.6 billion, missing the consensus of $33.3 billion. Adjusted EPS of $1.21 beat the consensus of $1.16.
&nbsp;
<h3>Equities Trading UP</h3>
<ul>
<li>Inpixon (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inpx#NASDAQ">INPX</a>) shares shot up 87% to $0.2848 after the company agreed to merge with XTI Aircraft Company.</li>
<li>Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/knsa#NASDAQ">KNSA</a>) got a boost, shooting 32% to $19.77 following strong quarterly results.</li>
<li>Bullfrog AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfrg#NASDAQ">BFRG</a>) shares were also up, gaining 34% to $4.63 after the company announced US patent for novel prodrugs of mebendazole and their use in treating cancer.</li>
</ul>
&nbsp;
<h3>Equities Trading DOWN</h3>
<ul>
<li>Humanigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hgen#NASDAQ">HGEN</a>) shares dropped 76% to $0.0464. Humanigen said it anticipates that it will not be able to continue as a going concern and is exploring all restructuring <a href="https://www.benzinga.com/money/best-options-to-buy-this-week/">options</a>, including bankruptcy.</li>
<li>Shares of Bellerophon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blph#NASDAQ">BLPH</a>) were down 39% to $0.4349 after the company received a delisting notice.</li>
<li>Stoke Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stok#NASDAQ">STOK</a>) was down, falling 33% to $ 6.36 after the company announced new safety and efficacy data from STK-001 in the two ongoing Phase 1/2a studies and the SWALLOWTAIL open-label extension study in children and adolescents with Dravet syndrome.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/07/33320550/top-4-tech-telecom-stocks-that-may-rocket-higher-in-july"> Top 4 Tech &amp; Telecom Stocks That May Rocket Higher In July</a>
&nbsp;
<h3>Commodities</h3>
In commodity news, oil traded up 1% to $79.52 while gold traded up 0.1% at $1,963.40.
Silver traded up 1% to $24.82 on Tuesday while copper rose 1.5% to $3.9140.
&nbsp;
<h3>Euro zone</h3>
European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 rose 0.48%, London&rsquo;s FTSE 100 rose 0.17% while Spain&rsquo;s IBEX 35 Index fell 0.25% The German DAX rose 0.13% French CAC 40 fell 0.16% and Italy&rsquo;s FTSE MIB Index rose 0.2%.
The Ifo Business Climate indicator for Germany declined for the third straight month to 87.3 in July. The CBI&#39;s quarterly gauge of manufacturing optimism in the UK rose to +6 in the third quarter compared to -2.0 in the prior three-month period.
&nbsp;
<h3>Asia Pacific Markets</h3>
Asian markets closed mixed on Tuesday, with Japan&rsquo;s Nikkei 225 falling 0.06%, China&rsquo;s Shanghai Composite Index gaining 2.13% and Hong Kong&rsquo;s Hang Seng Index gaining 4.10%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, fell 0.04%.
Exports from Hong Kong declined 11.4% year-over-year to $337.4 billion in June, while imports to Hong Kong fell 12.3% year-over-year to $393.9 billion.
&nbsp;
<h3>Economics</h3>
<ul>
<li>The S&amp;P CoreLogic Case-Shiller 20-city home price index declined 1.7% year-over-year in May, the same as in April.</li>
<li>The FHFA house price index increased by 0.7% versus the previous month in May.</li>
<li>The Manufacturing Activity Index in the Richmond area fell to -9 in July from -8 in June.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/07/33321238/these-analysts-cut-their-forecasts-on-csx-after-q2-results"> These Analysts Cut Their Forecasts On CSX After Q2 Results</a>
&nbsp;
<h3>COVID-19 Update</h3>
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,478,000 cases with around 1,169,620 deaths. India confirmed a total of at least 44,995,310 cases and 531,910 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 692,123,800 cases of COVID-19 worldwide with more than 6,902,510 deaths.

BFRG

HGEN

KNSA

STOK

Crude Oil Up 1%; Verizon Earnings Beat Views

<h3>Gainers</h3>
<ul>
<li>Bullfrog AI Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRG#NASDAQ">BFRG</a>) shares moved upwards by 33.8% to $4.63 during Tuesday's regular session. Trading volume for Bullfrog AI Hldgs's stock is 42.6 million as of 13:30 EST. This is 8458.3% of its average full-day volume over the last 100 days. The company's market cap stands at $28.2 million. </li>
<li>Kiniksa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) stock rose 32.66% to $19.82. Trading volume for Kiniksa Pharmaceuticals's stock is 3.0 million as of 13:30 EST. This is 719.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.3 billion. As per the press release, Q2 earnings came out today. </li>
<li>Galecto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLTO#NASDAQ">GLTO</a>) shares rose 28.51% to $3.02. As of 13:30 EST, this security is trading at a volume of 2.5 million shares, making up 3286.3% of its average full-day volume over the last 100 days. The company's market cap stands at $77.5 million. </li>
<li>Armata Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ARMP#AMEX">ARMP</a>) shares rose 23.56% to $1.94. As of 13:30 EST, Armata Pharmaceuticals's stock is trading at a volume of 294.2K, which is 594.9% of its average full-day volume over the last 100 days. The company's market cap stands at $70.1 million. </li>
<li>Genelux (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLX#NASDAQ">GNLX</a>) shares rose 20.12% to $24.35. Genelux's stock is trading at a volume of 54.3K shares as of 13:30 EST. This is 125.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $632.7 million. </li>
<li>Akebia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>) shares increased by 18.44% to $1.45. As of 13:30 EST, Akebia Therapeutics's stock is trading at a volume of 5.6 million, which is 298.4% of its average full-day volume over the last 100 days. The company's market cap stands at $268.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Humanigen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGEN#NASDAQ">HGEN</a>) stock fell 77.1% to $0.04 during Tuesday's regular session. The current volume of 90.6 million shares is 5964.9% of Humanigen's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $5.2 million. </li>
<li>Bellerophon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLPH#NASDAQ">BLPH</a>) shares decreased by 39.27% to $0.43. Bellerophon Therapeutics's stock is trading at a volume of 2.5 million shares as of 13:30 EST. This is 466.8% of its average full-day volume over the last 100 days. The company's market cap stands at $4.4 million. </li>
<li>NeuroOne Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTC#NASDAQ">NMTC</a>) stock fell 33.65% to $1.05. Trading volume for this security as of 13:30 EST is 1.3 million, which is 824.4% of its average full-day volume over the last 100 days. The company's market cap stands at $18.5 million. </li>
<li>Stoke Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) shares declined by 33.53% to $6.33. Trading volume for Stoke Therapeutics's stock is 3.8 million as of 13:30 EST. This is 1495.0% of its average full-day volume over the last 100 days. The company's market cap stands at $279.9 million. </li>
<li>9 Meters Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTR#NASDAQ">NMTR</a>) stock fell 32.86% to $0.09. The current volume of 3.0 million shares is 686.4% of 9 Meters Biopharma's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $1.2 million. </li>
<li>Tarsus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) stock decreased by 24.74% to $18.05. The current volume of 2.1 million shares is 1005.2% of Tarsus Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $483.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKBA

ARMP

GLTO

GNLX

NMTC

NMTR

TARS

12 Health Care Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Aurora Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aurc#NASDAQ">AURC</a>) shares jumped 192% to $30.54.</li>
<li>Inpixon (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inpx#NASDAQ">INPX</a>) gained 117% to $0.33 after the company agreed to merge with XTI Aircraft Company.</li>
<li>Electra Battery Materials Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elbm#NASDAQ">ELBM</a>) shares shot up 71.5% to $2.11 after jumping 22% on Monday. Electra Battery Materials said its battery grade cobalt supply agreement with LG Energy Solution has been extended and expanded from terms initially announced in Sept. 2022.</li>
<li>Bullfrog AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfrg#NASDAQ">BFRG</a>) shares gained 35.3% to $4.68 after the company announced US patent for novel prodrugs of mebendazole and their use in treating cancer.</li>
<li>Kiniksa Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/knsa#NASDAQ">KNSA</a>) climbed 31.7% to $19.68 following strong quarterly results.</li>
<li>Yoshiharu Global Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yosh#NASDAQ">YOSH</a>) shares gained 31.5% to $0.8425.</li>
<li>Steakholder Foods Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stkh#NASDAQ">STKH</a>) surged 29.4% to $1.3199. Steakholder Foods recently announced it signed its first multimillion dollar agreement with an accredited GCC governmental body to commercialize its 3D bio-printing technology.</li>
<li>Galecto, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glto#NASDAQ">GLTO</a>) gained 27.2% to $2.95.</li>
<li>HHG Capital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hhgc#NASDAQ">HHGC</a>) jumped 22.5% to $13.00.</li>
<li>Markforged Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mkfg#NASDAQ">MKFG</a>) jumped 21.7% to $1.9594.</li>
<li>American National Bankshares Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amnb#NASDAQ">AMNB</a>) gained 20.3% to $38.00 after reporting second-quarter results.</li>
<li>Akebia Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akba#NASDAQ">AKBA</a>) rose 19.7% to $1.46.</li>
<li>Rigetti Computing, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgti#NASDAQ">RGTI</a>) climbed 19.7% to $2.06.</li>
<li>Upstart Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upst#NASDAQ">UPST</a>) gained 19.5% to $64.19. BTIG maintained Upstart with a Buy and raised the price target from $42 to $72.</li>
<li>Applied Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apld#NASDAQ">APLD</a>) gained 18.5% to $10.40. Needham maintained Applied Digital with a Buy and raised the price target from $16 to $17.5.</li>
<li>Genelux Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnlx#NASDAQ">GNLX</a>) rose 18.4% to $23.99.</li>
<li>Shengfeng Development Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfwl#NASDAQ">SFWL</a>) gained 17.2% to $6.09.</li>
<li>Dunxin Financial Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dxf#NYSE">DXF</a>) climbed 16.8% to $1.73.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) rose 15.7% to $2.2215.</li>
<li>Carmell Therapeutics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctcx#NASDAQ">CTCX</a>) rose 15.4% to $4.0150 after falling over 36% on Monday.</li>
<li>Logitech International S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/logi#NASDAQ">LOGI</a>) rose 13.4% to $71.39 following strong quarterly results.</li>
<li>TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) gained 12.3% to $3.83.</li>
<li>POSCO Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pkx#NYSE">PKX</a>) rose 12% to $132.38 after Chinese leaders indicated support for stimulus measures. Economic stimulus measures in China could lift demand for metals and materials.</li>
<li>Packaging Corporation of America (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pkg#NYSE">PKG</a>) surged 10.3% to $153.00. The company late Monday reported mixed Q2 results.</li>
<li>Biophytis S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpts#NASDAQ">BPTS</a>) gained 9.2% to $2.01 after falling over 17% on Monday.</li>
<li>Hudbay Minerals Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hbm#NYSE">HBM</a>) rose 9.2% to $5.76 after Barclays upgraded the stock from Equal-Weight to Overweight.</li>
<li>Enzo Biochem, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/enz#NYSE">ENZ</a>) shares gained 8.8% to $1.48. Enzo Biochem closed a transaction to sell certain assets of Enzo&rsquo;s Clinical laboratory division to Laboratory Corporation of America Holdings.</li>
<li>Inter Parfums, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipar#NASDAQ">IPAR</a>) gained 8.5% to $142.09 after the company reported better-than-expected second-quarter revenue results and raised FY23 revenue guidance.</li>
<li>Anywhere Real Estate Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hous#NYSE">HOUS</a>) surged 8.3% to $8.31 following quarterly results.</li>
<li>AppHarvest, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apph#NASDAQ">APPH</a>) gained 8% to $0.0973. AppHarvest shares declined 73% on Monday after the company announced Chapter 11 filing to support a financial and operational transition.</li>
<li>Compass, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/comp#NYSE">COMP</a>) rose 7.4% to $4.2750.</li>
<li>Cleveland-Cliffs Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/clf#NYSE">CLF</a>) gained 7.4% to $17.74 after the company reported better-than-expected second-quarter revenue results.</li>
<li>Xerox Holdings Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xrx#NYSE">XRX</a>) climbed 7% to $16.58 after mixed second-quarter results and FY23 guidance boost.</li>
<li>Alcoa Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aa#NYSE">AA</a>) gained 6.4% to $35.92. Alcoa named Renato Bacchi as Executive Vice President and Chief Commercial Officer, effective Aug. 1, 2023</li>
<li>F5, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ffiv#NASDAQ">FFIV</a>) gained 5.7% to $158.73 as the company reported better-than-expected earnings for its third quarter.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Humanigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hgen#NASDAQ">HGEN</a>) shares fell 75.1% to $0.0476. Humanigen said it anticipates that it will not be able to continue as a going concern and is exploring all restructuring options, including bankruptcy.</li>
<li>Bellerophon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blph#NASDAQ">BLPH</a>) fell 38% to $0.4387 after the company received a delisting notice.</li>
<li>Stoke Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stok#NASDAQ">STOK</a>) fell 33% to $6.39 after the company announced new safety and efficacy data from STK-001 in the two ongoing Phase 1/2a studies and the SWALLOWTAIL open-label extension study in children and adolescents with Dravet syndrome.</li>
<li>NeuroOne Medical Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmtc#NASDAQ">NMTC</a>) fell 32% to $1.08. NeuroOne Medical priced the underwritten registered public offering of 5.25 million shares at $1.00 per share.</li>
<li>Rimini Street, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rmni#NASDAQ">RMNI</a>) fell 29.4% to $3.40. Rimini Street issued a statement on U.S. Federal Court Ruling.</li>
<li>Tarsus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tars#NASDAQ">TARS</a>) fell 23.9% to $18.25. The FDA has approved Tarsus Pharmaceuticals&#39; Xdemvy (Lotilaner Ophthalmic Solution, formerly TP-03) 0.25% For Demodex Blepharitisf</li>
<li>9 Meters Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmtr#NASDAQ">NMTR</a>) declined 23.4% to $0.0970.</li>
<li>Zevia PBC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zvia#NASDAQ">ZVIA</a>) dipped 23.3% to $3.2450 after announcing preliminary net sales for the second quarter.</li>
<li>Yellow Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yell#NASDAQ">YELL</a>) fell 22% to $1.0550.</li>
<li>Vertex Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtnr#NASDAQ">VTNR</a>) fell 21.1% to $5.18.</li>
<li>TrueBlue, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tbi#NYSE">TBI</a>) tumbled 17.8% to $15.02 after the company reported worse-than-expected second-quarter financial results.</li>
<li>PaxMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pxmd#NASDAQ">PXMD</a>) fell 15% to $0.7311. PaxMedica shares gained 7% on Monday after the released topline results from the PAX-101 (intravenous suramin) Phase 3 African Sleeping Sickness study.</li>
<li>Spotify Technology S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spot#NYSE">SPOT</a>) declined 14.3% to $140.34 after the company reported second-quarter earnings.</li>
<li>Sirius XM Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/siri#NASDAQ">SIRI</a>) fell 13.3% to $5.20.</li>
<li>iRobot Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/irbt#NASDAQ">IRBT</a>) dipped 12.7% to $40.95 after Amazon reduced the takeover price by 15% for debt adjustments.</li>
<li>RTX Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rtx#NYSE">RTX</a>) fell 12.7% to $84.61. The company in its earnings report disclosed that Pratt &amp; Whitney has determined that a rare condition in powder metal used to manufacture certain engine parts will require accelerated fleet inspection.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) declined 11.5% to $5.18 as the stock sees volatility after a court recently rejected the company&#39;s proposed plan to convert preferred shares to common units and implement a stock split.</li>
<li>Lytus Technologies Holdings PTV. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyt#NASDAQ">LYT</a>) shares fell 10.8% to $0.41.</li>
<li>Alaska Air Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alk#NYSE">ALK</a>) fell 9.3% to $48.38 after the company reported second-quarter financial results and issued guidance for third quarter and FY23.</li>
<li>Crown ElectroKinetics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crkn#NASDAQ">CRKN</a>) fell 9.2% to $0.0724 after declining 5% on Monday.</li>
<li>Mueller Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mli#NYSE">MLI</a>) declined 8.6% to $83.86 after the company reported worse-than-expected second-quarter revenue results.</li>
<li>Lamb Weston Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lw#NYSE">LW</a>) fell 8.5% to $103.09 following fourth-quarter earnings.</li>
<li>Sensata Technologies Holding plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/st#NYSE">ST</a>) declined 7.6% to $42.94 after the company reported second-quarter financial results and issued third-quarter guidance below estimates.</li>
<li>Spark Networks SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lov#NASDAQ">LOV</a>) fell 6.5% to $0.2590 after jumping 21% on Monday.</li>
<li>Rackspace Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxt#NASDAQ">RXT</a>) shares fell 5.8% to $2.42. Citigroup downgraded Rackspace Tech from Neutral to Sell and raised the price target from $1.25 to $1.5.</li>
<li>The Goodyear Tire &amp; Rubber Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gt#NASDAQ">GT</a>) declined 4.3% to $15.24.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/07/33369580/bitcoin-edges-lower-compound-becomes-top-loser"> Bitcoin Edges Lower; Compound Becomes Top Loser</a>

AMNB

APLD

BPTS

COMP

CRKN

CTCX

ELBM

FFIV

Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Comments

Bellerophon Therapeutics

Notizie

Ultime notizie per Bellerophon Therapeutics (OTC:BLPH) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO